Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Launches ELISA

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
Detection of new generation Synthetic Cannabinoids (Spice) drugs UR-144 and XLR-11.

Randox Toxicology has developed an ELISA targeting UR-144, XLR-11 and additional Synthetic Cannabinoid compounds which are commonly found in new ‘Spice’ and ‘K2’ blends.

These emerging compounds have been rapidly introduced to the designer drug market in response to legislation banning previously identified compounds.

As a result, other screening methods have since become out-dated, creating a difficult task for toxicologists who require a new way to detect the novel drugs.

Together with Randox Toxicology’s JWH/ AM2201 Synthetic Cannabinoids ELISA, the new UR-144/ XLR-11 ELISA provides a comprehensive solution for the rapid detection of over 55 current Synthetic Cannabinoids in urine, blood and oral fluid.

UR-144 and XLR-11 are chemically different structures to earlier generations of Synthetic Cannabinoids such as JWH-018, JWH-073 or AM-2201, and therefore are not detected by any other immunoassay product on the market.

The last decade has seen a proliferation in ‘designer drugs,’ developed by changing the molecular structure of one or more existing drugs to create a new substance.

Last week the United States Drug Enforcement Administration announced plans to schedule UR-144, XLR-11, and AKB48 which are often seen in falsely marketed “herbal incense” products. They are sold under various brand names, online, in head shops and even gas stations.

Despite many uncertainties, the use of these products is widespread and their detection is crucial in order to eradicate their use and damaging side effects.

The Randox Toxicology Synthetic Cannabinoids ELISA package delivers the most comprehensive cross reactivity profile on the market; allowing toxicologists to ensure that samples positive with new drug blends are not concealed.

A batch of samples can be economically processed with the 96 test kits, eliminating negative samples from further analysis.

Randox Toxicology is at the forefront of developing immunoassay solutions in response to the widespread designer drug movement. In addition to the new Synthetic Cannabinoids ELISA, Randox Toxicology offers a range of leading designer drug solutions including ELISAs for the detection of “Bath Salts” (Mephedrone, Methcathinone, MDPV) and a comprehensive 11-plex biochip array which can detect up to 110 novel drug compounds.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
Cellular Origin of Skin Cancer Identified
Scientists have identified ‘cell of origin’ in the most common form of skin cancer, and followed the process that leads to tumour growth.
Enhancing Drug Safety with a Web-Based Data Tool
Online and open-access tool allows anyone to find, combine and analyse FDA drug information.
Genetic Missing Link Could Explain Mystery of Heritability
Mother’s diet during pregnancy can permanently affect offspring attributes through process that could be strongly influenced by genetic variation in an unexpected part of the genome.
Does the Transport of Next-Gen Vaccines Lie with E.coli?
Study shows harmless E.coli capsule could aid next-gen vaccine delivery and efficiency.
Breathing in a Cure
Researchers working on inhalable ibuprofen to treat cystic fibrosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!